Residual Scope: Phase 3, Prospective, Randomized, Multi-Center Clinical Study Comparing the Safety and Efficacy of BAX855 Following PK Guided Prophylaxis Targeting Two Different FVIII Through Levels in Subjects with Severe Hemophilia A

Search results